Table: begin end state 1 42 cytoplasmic 43 65 transmembrane 66 76 non-cytoplasmic 77 93 transmembrane 94 113 cytoplasmic 114 132 transmembrane 133 158 non-cytoplasmic 159 181 transmembrane 182 200 cytoplasmic 201 221 transmembrane 222 227 non-cytoplasmic 228 249 transmembrane 250 253 cytoplasmic 254 274 transmembrane 275 293 non-cytoplasmic 294 315 transmembrane 316 336 cytoplasmic 337 367 transmembrane 368 380 non-cytoplasmic 381 404 transmembrane 405 415 cytoplasmic 416 440 transmembrane 441 462 non-cytoplasmic 463 485 transmembrane 486 490 cytoplasmic 491 509 transmembrane 510 521 non-cytoplasmic 522 543 transmembrane 544 562 cytoplasmic 563 592 transmembrane 593 614 non-cytoplasmic 615 642 transmembrane 643 661 cytoplasmic 662 683 transmembrane 684 688 non-cytoplasmic
Input: >3608576 MAVDIPQIEDPLETYEHILEHEERDRQPVAVALDNAVKGVGHVVMWANIALIAAIVAQVL FRYLLNQNFPKLDEIQWHFYGAVTMIGISYALVTDSHVRVDLLHMQLSRRSQRIIEVLGI LFLLVPLIYLMVDQGWDYFYESYRVNERSDSPTGLPLRWAFKAIIPISFVLLGIAAVARL IHDAHALWVGYEDERPGRGLGVVLMALLAFAVVGFGLSFLVETTEEKLVVAMFITFIALL FTGYPVAWVLSGVGVAYCGLAFLFDNDLMLWTGLEGTLTGLDYLTLGATVNRVYATMSNA VLVALPMFIFMGLMLDESGVAERLMTSMQRLFGKTRGGLAITVTMIGIILAASTGIIGAS VVLLGVLSLPAMMQQKYSPRLAAGVVSASGTLGILIPPSIMLVIMADQMALSVGDLFMAA VFPGVIIGGLYLVYIFVISYLKPDVAPVPEGAQSPDWQAVKDVMVAVLPTLGLILAVLGS IFAGICTPTEASGIGALGATLLALGYRKLTLHKLVNVLVSTFNTTAYIFAIFLGATVFSY VLRELGGDALIEHMIAATGLGPNGTILFILFIVFLLGFVLDWIEITLIVLPLMRPIVNAL GMDIPGFGVLDEPTLVWFVILVAVTLQTSFLTPPVGFALFYLKGVCPPEIKLLDIYKGII PFVLLQLTGLALVFLLPALATWLPSVAY
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server